Dr. Emmanuel Yumang and other select KHP physicians are earning triple points toward their quality scores by closing gaps with the Statin Use in Persons with Diabetes (SUPD) measure. The measure recommends moderate to high intensity statin therapy for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in persons 40-75 years old with diabetes.
“I want all of my diabetic patients to be at their target LDL. I even downloaded an app to show patients the ACC/AHA Heart Risk Calculator,” said Dr. Yumang. “I feel if my patients can visualize their risk factors, they can better understand – more so than just by me telling them. I like to show them their risks and review each individual factor so they can be informed about making decisions on their care.”
Dr. Yumang already has a high SUPD score, but says he is striving for 100% compliance. Other KHP providers have significant opportunity to improve scores with this triple-weighted measure.
SUPD Measure: Statin Use in Persons with Diabetes
• Recommends moderate to high intensity statin therapy for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in persons 40-75 years old with diabetes.
• TRIPLE WEIGHTED quality measure, developed and endorsed by the Pharmacy Quality Alliance (PQA) in 2014 and adopted within the Centers for Medicare & Medicaid Services (CMS) 2019 Star ratings.
How can you meet the measure? Ensure that your diabetic patients 40-75 years old are prescribed a statin medication at least once, unless there is a contraindication to therapy. Contraindications include pregnancy, active liver disease, statin allergy, and unexplained persistent elevations of serum transaminases.
Consider prescribing one of the low cost generic statin medications to help offset costs, which may also help with medication adherence barriers due to financial concerns. Explain the efficacy of statin therapy in reducing their risk for cardiovascular events, particularly since these diabetic patients are at a substantially higher lifetime risk for ASCVD events and experience greater morbidity and worse survival rates following the start of clinical ASCVD.
How is the SUPD measure calculated?
The measure represents the percentage of Medicare Part D beneficiaries 40-75 years old who were dispensed at least two diabetes medication fills and received a statin medication fill. Only pharmacy claims are used, and one fill of a statin medication will close this measure. A higher rate represents better performance. Patients are considered diabetic if they were dispensed two or more prescription fills of an oral diabetes medication, injectable incretin mimetic, or insulin during the measurement year. Beneficiaries enrolled in hospice and those patients with end-stage renal disease (ESRD) are not included in the measure.